Hansen Medical to Highlight Sensei Robotic Catheter System Alongside Cohesion 3-D Visualization Module at Boston Atrial Fibrilla
15 1์ 2009 - 10:30PM
Marketwired
Booth # 401 -- Hansen Medical, Inc. (NASDAQ: HNSN) will showcase
its Sensei๏ฟฝ Robotic Catheter System and the CoHesion(TM) 3-D
Visualization Module here at the 14th Annual Boston Atrial
Fibrillation Symposium, Jan. 15-17, 2009. The integrated
electrophysiology (EP) solution offers physicians a software
interface between Hansen Medical's robotic catheter system and St.
Jude Medical's EnSite(TM) System advanced mapping technology. It is
designed to provide physicians with 3-D visualization to enhance
their ability to move a catheter throughout the heart and is
intended to optimize control over catheter placement in specific
locations.
"It is our goal to continue to offer physicians technological
solutions that provide confidence and accuracy during complex
procedures," said Gary Restani, president and COO of Hansen
Medical. "Clinicians using the Sensei system and the integrated 3-D
visualization module report confidence in catheter placement and
navigation, as well as a reduction in fluoroscopy time.
"We are very encouraged by the broad adoption of our technology
worldwide with 55 systems shipped through 2008 and well over 1,000
clinical cases reported using the Sensei system, many of which have
been completed using our integrated solution," continued
Restani.
The CoHesion interface expands the utility of the EnSite System
and Sensei systems to provide physicians with a comprehensive and
easy-to-use remote navigation and mapping system for EP procedures.
The EnSite system provides visualization and localization for
detection of EP catheters in 3-D space within the heart chamber,
while the Sensei system is designed to permit remote movement of
catheters in 3-D. By integrating both products, Hansen Medical
believes physicians should be able to navigate more instinctively
within the 3-D cardiac space because the system enables
visualization and catheter movement in 3-D.
"The Sensei system with the CoHesion interface is truly
innovative because it allows for very accurate catheter
manipulation and catheter stability," said Patrick Hranitzky, M.D.,
assistant professor of medicine and director of Clinical Cardiac
Electrophysiology at Duke University Medical Center in Durham,
N.C.
"In addition, the ability to perform complex and potentially
long procedures while seated at the workstation without wearing the
heavy lead could lead to greater career longevity for clinicians.
Therefore, I prefer the Sensei system for all of my complex cardiac
procedures," continued Dr. Hranitzky.
St. Jude Medical's EnSite System is an advanced computer-based
technology for mapping the electric activity for the heart, and for
localizing and visualizing EP catheters in real-time. The EnSite
System creates 3-D graphical displays of cardiac structures and
arrhythmias, and enables catheter navigation without the use of
fluoroscopy.
The Sensei system uses flexible medical robotics technology to
provide stable and predictable control of catheter movement inside
the heart. This innovative technology is designed to provide fine
catheter control while mapping in 3-D to enhance the physician's
ability to access hard-to-reach anatomy, and to maintain stability
during complex cardiac arrhythmia procedures. The physician
workstation is adaptable to existing EP lab suites and can be
placed away from the field of direct radiation. The disposable
Artisan(TM) Control Catheter is comprised of inner and outer
steerable guide catheters that accommodate existing pre-approved
percutaneous catheters. And, with the IntelliSense๏ฟฝ Fine Force
Technology, clinicians have access to real-time measurement and
display of the proximal force along the shaft of percutaneous
catheters.
About Hansen Medical, Inc.
Hansen Medical Inc., based in Mountain View, Calif., develops
products and technology using robotics for the accurate
positioning, manipulation and control of catheters and
catheter-based technologies. Its first product, the Sensei(TM)
Robotic Catheter system, is compatible with fluoroscopy,
ultrasound, 3-D surface map and patient electrocardiogram data and
was cleared by the U.S. Food and Drug Administration (FDA) in May
2007 for manipulation and control of certain mapping catheters in
Electrophysiology (EP) procedures. The safety and effectiveness of
the Sensei system for use with cardiac ablation catheters in the
treatment of cardiac arrhythmias, including atrial fibrillation
(AF), have not been established. The Sensei system is CE Marked for
use during EP procedures, such as guiding catheters in the
treatment of AF. Additional information can be found at
www.hansenmedical.com.
Forward-Looking Statements
This press release contains forward-looking statements
regarding, among other things, statements relating to expectations,
goals, plans, objectives and future events. Hansen Medical intends
such forward-looking statements to be covered by the safe harbor
provisions for forward-looking statements contained in Section 21E
of the Exchange Act and the Private Securities Litigation Reform
Act of 1995. Examples of such statements include statements about
the creation of integrated products and the resulting benefits of
such products. These statements are based on the current estimates
and assumptions of Hansen Medical management as of the date of this
press release and are subject to risks, uncertainties, changes in
circumstances, assumptions and other factors that may cause actual
results to differ materially from those indicated by
forward-looking statements. Important factors that could cause
actual results to differ materially from those indicated by such
forward-looking statements include, among others, the risks and
uncertainties inherent in Hansen Medical's business, including
potential safety and regulatory issues that could slow or suspend
its sales; its ability to effectively sell, service and support its
products; the scope and validity of intellectual property rights
applicable to its products; competition from other companies; and
its ability to obtain additional financing to support its
operations. These and other risks are described in greater detail
under the heading "Risk Factors" contained in Hansen Medical's
periodic SEC filings, including its Quarterly Report on Form 10-Q
filed with the SEC on November 5, 2008. Given these uncertainties,
you should not place undue reliance on these forward-looking
statements. Hansen Medical undertakes no obligation to revise or
update information herein to reflect events or circumstances in the
future, even if new information becomes available.
Sensei, IntelliSense, Hansen Medical and Heart Logo and Hansen
Medical Heart Logo are registered trademarks and Artisan and
CoHesion are trademarks of Hansen Medical Inc. in the United States
and other countries.
EnSite is a trademark of St. Jude Medical.
Media Contact: Amy Cook 925.552.7893 Email Contact Investor
Contact: Steven Van Dick 650.404.5800 Email Contact
Hansen Medical, Inc. (MM) (NASDAQ:HNSN)
๊ณผ๊ฑฐ ๋ฐ์ดํฐ ์ฃผ์ ์ฐจํธ
๋ถํฐ 6์(6) 2024 ์ผ๋ก 7์(7) 2024
Hansen Medical, Inc. (MM) (NASDAQ:HNSN)
๊ณผ๊ฑฐ ๋ฐ์ดํฐ ์ฃผ์ ์ฐจํธ
๋ถํฐ 7์(7) 2023 ์ผ๋ก 7์(7) 2024